Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Topical Ruxolitinib for Immune Checkpoint Inhibitor–Induced Vitiligo
Topical Ruxolitinib for Immune Checkpoint Inhibitor–Induced Vitiligo
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Federico Venturi
,
Ina Sotiri
,
Barbara Melotti
,
Monika Fida
,
Emi Dika
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
International Journal of Dermatology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1111/ijd.70367
Similar Items
Topical Ruxolitinib as an Effective Therapy for Vitiligo‐Like Lesions Induced by Anti‐ PD ‐1 Therapy
by: Lorenzo Maria Pinto, et al.
Published: (2025)
Longitudinal Dermoscopic and LC ‐ OCT Monitoring of Facial Vitiligo Treated With Topical Ruxolitinib: A Pilot Prospective Study
by: Luca Ambrosio, et al.
Published: (2026)
Immune Checkpoint Inhibitor–Associated Autoimmune Bullous Diseases: Beyond Bullous Pemphigoid
by: Ioannis‐Alexios Koumprentziotis, et al.
Published: (2026)
Effectiveness and Safety of Ruxolitinib Cream 15 mg/g in Patients With Non‐Segmental Vitiligo: A Real‐Life Study
by: Mattia Cristallo, et al.
Published: (2025)
Predictors of Response to Topical Ruxolitinib in Non‐segmental Vitiligo: A Narrative Review
by: Luca Bettolini, et al.
Published: (2026)